APOE and Alzheimer disease: Considering the diagnostic criteria stablished by the National Institute on Aging-Alzheimer’s Association workgroups [27], neither CSF biomarkers nor APOE genotyping stand for higher prevalence of AD in sIBM patients when compared with age bracket control data.